These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 18607390)
1. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390 [TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Zheng ZH; Li XY; Ding J; Jia JF; Zhu P Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486 [TBL] [Abstract][Full Text] [Related]
5. Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules. Chen X; McClurg A; Zhou GQ; McCaigue M; Armstrong MA; Li G Stem Cells; 2007 Feb; 25(2):364-70. PubMed ID: 17068184 [TBL] [Abstract][Full Text] [Related]
6. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15. Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856 [TBL] [Abstract][Full Text] [Related]
7. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses. Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049 [TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Nasef A; Mazurier C; Bouchet S; François S; Chapel A; Thierry D; Gorin NC; Fouillard L Cell Immunol; 2008; 253(1-2):16-22. PubMed ID: 18639869 [TBL] [Abstract][Full Text] [Related]
10. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin. Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830 [TBL] [Abstract][Full Text] [Related]
11. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367 [TBL] [Abstract][Full Text] [Related]
12. The inhibition of T-cells proliferation by mouse mesenchymal stem cells through the induction of p16INK4A-cyclin D1/cdk4 and p21waf1, p27kip1-cyclin E/cdk2 pathways. Kim JA; Hong S; Lee B; Hong JW; Kwak JY; Cho S; Kim CC Cell Immunol; 2007 Jan; 245(1):16-23. PubMed ID: 17470365 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. Rasmusson I; Uhlin M; Le Blanc K; Levitsky V J Leukoc Biol; 2007 Oct; 82(4):887-93. PubMed ID: 17609339 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia. Zhao ZG; Li WM; Chen ZC; You Y; Zou P Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219 [TBL] [Abstract][Full Text] [Related]
16. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384 [TBL] [Abstract][Full Text] [Related]
17. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Maitra B; Szekely E; Gjini K; Laughlin MJ; Dennis J; Haynesworth SE; Koç ON Bone Marrow Transplant; 2004 Mar; 33(6):597-604. PubMed ID: 14716336 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749 [TBL] [Abstract][Full Text] [Related]
19. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159 [TBL] [Abstract][Full Text] [Related]
20. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Groh ME; Maitra B; Szekely E; Koç ON Exp Hematol; 2005 Aug; 33(8):928-34. PubMed ID: 16038786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]